Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
ULURU Inc. · with Navy Advanced Medical Development (NAMD) Command · NCT05424354
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–65 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 60
- US sites recruiting
- 6
- Study start
- May 26, 2022
- Record last updated
- November 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.
Being studied: Altrazeal (R) Transforming Powder Dressing; Standard of Care burn dressing
Conditions: Wounds and Injuries
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Hospitalized patients who are receiving burn care; patients may be discharged when clinically stable and continue with outpatient treatment.
- Men and women (women cannot be pregnant or breast feeding) ages 18-65 years old
- Wounds must be partial thickness, involving up to 20% of the total body surface area.
- Burn injury should be less than 72 hours old
- Willing and able to comply with protocol mandated scheduled study visits/clinical evaluations.
- Willing and able to provide written informed consent.
Exclusion Criteria
- Known allergy to TPD or its components
- Women who are pregnant, breast feeding, or plan to get pregnant during the study period.
- Infected wounds
- Presence of any full thickness (third degree) burns
- Electrical burns
- Heavily draining burns due to underlying chronic lymphedema or other conditions
- Concurrent clinical condition within the judgement of the clinician, pose a health risk to the patient, delay wound healing, or otherwise influence the outcome of the study.
- History of poor wound healing and/or skin/immune system condition
- Deemed by clinician not to be suitable
- Unwilling or not able to provide consent or comply with protocol or required visits
- Developmental disability/significant psychological disorder which can impair the subjects ability to provide informed consent, or participate in the study protocol
- Active alcohol or substance abuse
Recruiting US locations
University of California-Irvine
Orange, CA 92868
Site contact: Lizette Spears · 714-456-5840 · lspiers@hs.uci.edu
MedStar Washington Hospital Center
Washington D.C., DC 20010
Site contact: Mary (Abby) Bellon · 202 877 3519 · Mary.A.Bellon@medstar.net
Jackson Memorial Hospital UM/JMH Burn Center
Miami, FL 33136
Site contact: Lisa Otero, BA · 305-585-1348 · lao77@med.miami.edu
University of Louisville Health
Louisville, KY 40202
Site contact: Madison Rutledge · (502) 629-3327 · madison.rutledge@louisville.edu
Westchester Medical Center
Valhalla, NY 10595
Site contact: Daniela Santamaria-Vargas, MSc · 9144931528 · Daniela.Santamaria-Vargas@wmchealth.org
University of Texas SW (Parkland)
Dallas, TX 75235
Site contact: Scarlett Dwyer · 214 645-0445 · Scarlett.Dwyer@utsouthwestern.edu
Study contacts (from the official record)
- Vai Shah · 2149055145 · vshah@uluruinc.com
- Susan St John, MSN · 4123035379 · sstjohn@uluru.com
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55